share_log

Eve & Co Announces Shares for Debt Transaction

Eve & Co Announces Shares for Debt Transaction

Eve&Co宣布股票进行债务交易
GlobeNewswire ·  2022/01/31 08:36

STRATHROY, Ontario, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Eve & Co Incorporated ("Eve & Co" or the "Company") (TSX-V: EVE; OTCQX: EEVVF) is pleased to announce it has entered into debt settlement agreements (the "Debt Settlement Agreements") with certain directors, officers, employees, and debentureholders (the "Parties") whereby it has agreed to settle an aggregate of $657,000 in payables (the "Payables") owed to the Parties related to expenses, loans and services rendered to the Company up to January 2022 in exchange for an aggregate of 5,189,606 common shares in the capital of the Company (the "Settlement Shares"). The Company is proposing to issue the Settlement Shares to settle the Payables in order to preserve cash for general working capital purposes.

安大略省斯特拉特罗伊,2022年1月31日(环球社)--伊夫公司(Eve&Co Inc.)Eve&Co“或”公司“)(多伦多证券交易所-V:EVE;OTCQX:EEVVF)很高兴地宣布,它已达成债务解决协议(”债务清偿协议)与某些董事、高级管理人员、员工和债券持有人(各方“)据此,同意结清总计657,000美元的应付账款(”应付款)欠各方与截至2022年1月向本公司提供的费用、贷款和服务有关的费用、贷款和服务,以换取本公司股本中总计5,189,606股普通股(结算股份“)。本公司建议发行结算股份以结清应付款项,以保存现金作一般营运资金用途。

Pursuant to the terms of the Debt Settlement Agreements, the Company has agreed to issue an aggregate of 908,677 Settlement Shares at a deemed issuance price of $0.12 per Settlement Share in full and final satisfaction of $109,041 of certain trade payables, directors' fees, and salaries and an aggregate of 4,280,929 Settlement Shares at a deemed issuance price of $0.128 per Settlement Share in full and final satisfaction of $547,959 owed to the holders of the Company's outstanding 10% unsecured convertible debentures that were issued on December 11, 2020.

根据债务和解协议的条款,本公司已同意发行合共908,677股结算股份,当作发行价为每股结算股份0.12美元,以全数及最终清偿109,041美元的若干贸易应付款项、董事酬金及薪金,以及合共4,280,929股结算股份,以每股结算股份0.128美元的当作发行价全数及最终清偿欠本公司于2020年12月11日发行的未偿还10%无担保可转换债券持有人的547,959美元

Insiders of the Company (the "Insiders") are expected to receive 1,916,667 Settlement Shares in settlement of $242,500 of debt. Pursuant to Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions ("MI 61-101"), the settlement of the Payables will constitute a "related party transaction" as the Insiders are considered to be related parties to the Company. The Company will rely on exemptions from the formal valuation and minority approval requirements of MI 61-101 (pursuant to subsections 5.5(a) and 5.7(a)) as the fair market value of the securities to be distributed to, and the consideration received from, the Insiders will not exceed 25% of the Company's market capitalization. The settlement of the Payables has been approved by all of the independent directors of the Company. All securities issued pursuant to the Debt Settlement Agreements will be subject to statutory and TSX Venture Exchange ("TSXV") hold periods until the date that is four months and one day from the date of issuance.

本公司内部人士(“内部人士“)预计将获得1,916,667股结算股份,以清偿242,500美元的债务。根据多边文书61-101-特殊交易中少数股权持有人的保护("米其林61-101“),应付款项的结算将构成”关联方交易“,因为内部人士被视为本公司的关联方。本公司将依据豁免MI 61-101(根据第5.5(A)和5.7(A)款)的正式估值和少数股东批准的要求,作为将分配给内部人士的证券的公平市值,并从内部人士收取不超过本公司市值的25%的对价。应付款项的结算已获本公司全体独立董事批准。根据债务清偿协议发行的所有证券将受法定和多伦多证券交易所(TSX)风险交易所(“TSXV“)持有期限至发行之日起四个月零一天为止。

Settlement of the Payables and issuance of the Settlement Shares is subject to the acceptance of the TSXV. There is no guarantee that such conditions precedent will be satisfied or that any of the transactions will be completed as described herein or at all.

应付款项的结算及结算股份的发行须经天津市证券及期货事务监察委员会接纳。不能保证这些先例会得到满足,也不能保证任何交易都会如本文所述那样完成,或者根本不能保证。

ABOUT EVE & CO

关于Eve&CO

Eve & Co, through its wholly-owned subsidiary Natural Medco Ltd. ("NMC"), holds cultivation and processing licences under the Cannabis Act (Canada) for the production and sale of various cannabis products, including dried cannabis, cannabis plants and extraction of cannabis oil and has received its European Union certificate of Good Manufacturing Practice. NMC was Canada's first female-founded licensed producer of medicinal marijuana and received its cultivation licence from Health Canada in 2016. Eve & Co is led by a team of agricultural experts and has a licensed 1,000,000 square foot greenhouse located in Strathroy, Ontario. 

Eve&Co通过其全资子公司Natural Medco Ltd.(“NMC“),根据大麻法案加拿大负责生产和销售各种大麻产品,包括干大麻、大麻植物和大麻油提取,并已获得欧洲联盟良好制造规范证书。NMC是加拿大第一家由女性创立的有执照的医用大麻生产商,并于2016年从加拿大卫生部获得种植许可证。Eve&Co由一个农业专家团队领导,在安大略省斯特拉特里拥有100万平方英尺的温室许可。

The Company's website can be visited at .

该公司的网站可通过以下网址访问:

Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

TSXV及其监管服务提供商(该术语在TSXV的政策中定义)均不对本新闻稿的充分性或准确性承担责任。

This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur, and include, but are not limited to, the negative of these words or other variations on these words or comparable terminology. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements and readers should not place undue reliance on such statements. Forward-looking statements contained in this release include statements with respect to the completion of the debt settlement contemplated in the Debt Settlement Agreements and the ability of the Company to attain the TSXV approval required for the issuance of the Settlement Shares, amongst other matters. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking statements, including general business and economic conditions, changes in laws and regulations, product demand, changes in prices of required commodities, competition, the effects of and responses to the COVID-19 pandemic and other risks, uncertainties and factors set out under the heading "Risk Factors" in the Company's management's discussion and analysis dated April 30, 2021 (the "MD&A") and filed with Canadian securities regulators available on the Company's issuer profile on SEDAR at . The Company cautions that the list of risks, uncertainties and other factors described in the MD&A is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such information. These forward-looking statements speak only as of the date on which they are made, and the Company undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances unless otherwise required to do so by law.

本新闻稿包括含有适用证券法定义的某些“前瞻性信息”的陈述(“前瞻性陈述”)。前瞻性表述经常使用诸如“计划”、“继续”、“预期”、“项目”、“打算”、“相信”、“预期”、“估计”、“可能”、“将”、“潜在”、“建议”等类似词语,或某些事件或条件“可能”或“将”发生的表述,包括但不限于这些词语的负面影响或这些词语或类似术语的其他变体。尽管公司认为这些前瞻性陈述中表达的预期是基于合理的假设,但这些陈述并不是对未来业绩的保证,涉及难以控制或预测的风险和不确定因素。因此,实际结果和结果可能与这些前瞻性陈述中表达的大不相同,读者不应过分依赖这些陈述。本新闻稿中包含的前瞻性陈述包括有关债务清偿协议中预期的债务清偿完成的陈述,以及本公司获得发行结算股所需的多伦多证券交易所(TSXV)批准的能力以及其他事项的陈述。前瞻性表述受各种风险、不确定因素和其他因素的影响,管理层认为这些因素在当时的情况下是相关和合理的,可能会导致实际事件、结果、活动水平、业绩、前景、机会或成就与前瞻性表述中预测的结果大不相同,包括总体商业和经济状况、法律法规的变化、产品需求、所需商品的价格变化、竞争、“新冠肺炎”疫情的影响和应对以及其他风险。, 在公司管理层于2021年4月30日提交给加拿大证券监管机构的讨论和分析(“MD&A”)中“风险因素”标题下列出的不确定因素和因素可在公司在SEDAR上的发行人简介中查阅,网址为。该公司告诫说,MD&A中描述的风险、不确定因素和其他因素并不是详尽的,其他因素也可能对其结果产生不利影响。请读者在评估前瞻性陈述时仔细考虑风险、不确定性和假设,并告诫读者不要过度依赖这些信息。这些前瞻性陈述仅在发表之日发表,公司没有义务公开更新这些陈述,以反映新的信息或未来事件或情况的发生,除非法律另有要求。

For further information, please contact:

如需更多信息,请联系:

Melinda Rombouts
President and Chief Executive Officer Eve & Co Incorporated
Telephone: (855) 628-6337

梅林达·罗伯茨
总裁兼首席执行官Eve&Co Inc.
电话:(855)628-6337

47420341.2

47420341.2


声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发